# Feel Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/feel-therapeutics

- Industry: Healthcare Specialists
- Headquarters: San Francisco, US
- Website: www.feeltherapeutics.com/
- Total disclosed funding: $5M
- Latest round: Seed (Oct 10, 2019)
- Investors on record: 3

## About

Established in 2015 and based in California, US, Feel Therapeutics Inc. engages in the research and development of mental health solutions such as wearables and digital health apps to monitor those patients who have mental health issues. George Eleftheriou (CEO) and Haris Tsirmpas (CTO) are the co-founders of the company. In June 2024, Feel Therapeutics Inc. raised USD 3.5 million in venture funding from investors.

The company specializes in advancing mental health care through objective measurement tools and digital biomarkers. The firm is developing and deploying digital precision medicine for mental health, utilizing continuous 24/7 data collection from wearables, apps, and mobile devices. Feel Therapeutics’ solutions include FEEL 360 for clinical trials, FEEL DTx for precision interventions, and FEEL WELL for stress and emotional wellbeing. The company enhances mental health diagnosis, management, and treatment, improving outcomes for conditions such as depression, anxiety, and ADHD.

## Funding rounds

- Seed, Oct 10, 2019, $4.5M — Felicis Ventures, Anthemis, SOSV
- Seed, Dec 31, 2018 — SOSV
- Seed, Nov 28, 2018 — SOSV
- Seed, Dec 20, 2017 — Anthemis, SOSV
- Seed, Oct 24, 2017 — SOSV
- Seed, Sep 9, 2016 — SOSV
- Seed, Jan 17, 2016, $0.5M — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- Anthemis (https://capitalatlas.ai/funds/anthemis) — Seed
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Seed